PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a finished-dose generic company from Taiwan

Selling into Europe as a finished-dose generic company from Taiwan

Your Taiwan team builds European generic dossiers that clear validation the first time.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Taiwan, Finished-dose generic companywho it is written for

Why this training matters

A validation officer finds one missing Module 1 document in your Marketing Authorisation Application and sends the file back. Your team rebuilds the package while the launch slips by months. A competitor takes the shelf space and your finished doses wait in a warehouse in Taiwan.

What changes after this course

Your regulatory team picks the right procedure, builds the electronic Common Technical Document to the technical rules and answers assessor questions inside the clock-stop. You hold a certificate for each learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory team stops debating the route in meeting rooms. They look at the target countries, check for an existing national authorisation and pick the Centralised, Decentralised or Mutual Recognition Procedure in one sitting. The dossier then follows the Common Technical Document layout, and Module 1 carries what the validation officer checks for.

A European competent authority announces an inspection of your Taiwan site, and your quality head already knows the answers to the questions EudraLex Volume 4 raises. Batch records and quality control logs are ready to hand over. The inspector asks, the document is on the table, and the export timeline holds.

A hospital buyer in Europe asks when you can supply. Your export manager answers from a sheet that shows originator patent expiry and any Supplementary Protection Certificate, country by country. When a pricing or reimbursement body asks for data, the submission follows that member state's rules instead of a generic template.

After approval, the work continues, and your team is ready for it. Regulatory staff separate Type IA from Type IB variations and file them on time after a manufacturing change. Your Qualified Person for Pharmacovigilance gets the adverse reaction reports needed for European Union reporting deadlines, without a consultant on call.

Who needs this training

  • Regulatory Affairs Manager

    Your electronic Common Technical Document is rejected at the technical gateway and the submission window is closing. You need to know which validation error it is and how to fix it today.

  • Quality Assurance Head

    A European authority schedules an inspection of your Taiwan site. You must show batch records and quality control testing that meet EudraLex Volume 4 before the inspector walks in.

  • Export Sales Manager

    A hospital buyer in Europe asks for your launch date. You need to say when the originator patent and any Supplementary Protection Certificate expire, and answer on the call.

  • Business Development Director

    You build next year's revenue forecast and must account for national pricing, reimbursement listing and tender cycles across several European member states, each with its own rules.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Finished-dose generic company

Countries: Taiwan

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Assemble a finished-dose generic dossier that follows the Common Technical Document structure and clears the validation phase.
  2. Choose the Marketing Authorisation Procedure that fits your list of target countries, and defend the choice to your board.
  3. Draft answers to a Request for Information and send them before the clock-stop period ends.
  4. Prepare your Taiwan site and its batch records for a European Good Manufacturing Practice inspection under EudraLex Volume 4.
  5. List originator patent and Supplementary Protection Certificate expiry dates for your target molecules in each European country.
  6. File the correct Type IA or Type IB variation after a manufacturing change.

What the company gets

  • Your finished-dose generic dossiers reach the validation phase complete, so launch dates are not lost to a returned file.
  • Your Taiwan site meets a European inspector with batch records and testing logs that answer the questions before they are asked.
  • Your sales team quotes launch dates built from procedure timelines, patent expiry and tender cycles instead of hopeful estimates.
  • Your legal exposure falls because each originator patent and Supplementary Protection Certificate is tracked before the first consignment ships.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Name the European authority that handles each of your applications

    • Why some applications go to the European Medicines Agency and others to a national authority.
    • How to find the right national competent authority for your target country before you write a word.
    • The reason Germany and the United Kingdom now need separate files, and what that does to your plan.
  2. 2Choose the Marketing Authorisation Procedure that fits your target countries

    • When the Centralised Procedure is open to your generic, and when it is not.
    • How to pick Decentralised or Mutual Recognition by checking if a national authorisation already exists.
    • Why choosing the Reference Member State is a commercial decision, not a formality.
  3. 3Build a finished-dose generic dossier that passes the validation phase

    • How to lay out the dossier so an assessor finds each answer where they first look.
    • The Module 1 administrative gaps that send a file back at validation, and the checklist that catches them.
    • What European guidelines expect from your bioequivalence study before you place it in Module 5.
  4. 4Prove quality, safety and efficacy with the data assessors expect

    • How to document your active substance source so the Module 3 quality section holds together.
    • The Module 3 quality data an assessor looks for in a generic application.
    • What goes in the nonclinical and clinical overviews so the reviewer sees why no new trials are needed.
  5. 5Compile the electronic Common Technical Document with no validation errors

    • How to format the electronic Common Technical Document so it clears the technical validation check.
    • The Extensible Markup Language backbone mistakes that stop a submission before anyone reads it.
    • What to do when you must update the dossier after submission, using the right lifecycle sequence.
  6. 6Book pre-submission meetings with European authorities and arrive prepared

    • When to send the letter of intent to the European Medicines Agency ahead of a Centralised application.
    • How to build the briefing package so your pre-submission meeting ends with answers, not homework.
    • The fee steps that must be settled before the agency starts work on your file.
  7. 7Answer assessor Requests for Information inside the clock-stop

    • How to write a Request for Information response that closes the assessor's question in one round.
    • The clock-stop timelines that keep your application alive, and how to ask for more time.
    • What to do when an assessor reads your stability data differently from how you meant it.
  8. 8File variations and keep post-authorisation commitments on schedule

    • How to tell a Type IA variation from a Type IB variation before you file the wrong one.
    • Why your Qualified Person for Pharmacovigilance needs direct access to your safety data.
    • The reporting timelines for adverse drug reactions under European Union law, kept in one calendar.
  9. 9Pass European Good Manufacturing Practice inspections at your Taiwan site

    • How to prepare your Taiwan site for a European inspection so no one scrambles the week before.
    • The EudraLex Volume 4 requirements that catch out sites outside Europe.
    • What to show the inspector in batch records and quality control testing to close questions on the spot.
  10. 10Price your generics so European reimbursement systems list them

    • How pricing and reimbursement bodies decide whether your generic gets listed.
    • The hospital tender rules that decide who supplies the ward, and how to bid for them.
    • Why a low price in one member state can pull down your price in others.
  11. 11Clear patent and Supplementary Protection Certificate hurdles before launch

    • How to track originator patent expiry in each target country on one sheet.
    • The Supplementary Protection Certificate extensions that push your launch date later than patent expiry.
    • What to check before shipping, so a patent claim does not stop your first consignment.
  12. 12Write the strategic plan that sets your European market entry date

    • How to line up submission dates with national tender cycles.
    • The critical path milestones that set your real launch date, and who owns each.
    • What a finished market entry plan looks like when you put it in front of your board.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Taiwan, Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team